Sean will drive the Company through its next phase of growth and bring its highly promising pipeline through clinical development He brings more than 20 years of senior executive experience in the life science industry across business development, op
STRASBOURG, France & MONTREAL & BOSTON -- Domain Therapeutics a global clinical-stage biopharmaceutical company developing innovative drug candidates in immuno-oncology targeting G Protein-Coupled Receptors (GPCRs), today announces the appointment of Sean A. MacDonald as its Chief Executive Officer (CEO). Read More
